Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong
· Delayed Price · Currency is HKD 0.2400
-0.0030 (-1.23%)
May 30, 2025, 3:50 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 311.29 million as of May 30, 2025. Its market cap has decreased by -42.86% in one year.
Market Cap
311.29M
Enterprise Value
-36.03M
Revenue
40.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 311.29M, a decrease of -97.93%. That is a compound annual growth rate of -66.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 311.29M | -0.41% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 229.25B |
| Hansoh Pharmaceutical Group Company | 153.70B |
| JD Health International | 128.48B |
| Innovent Biologics | 102.19B |
| WuXi Biologics | 101.51B |
| CSPC Pharmaceutical Group | 92.57B |
| Sino Biopharmaceutical | 79.63B |
| Akeso | 75.22B |